iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares LALPATHLAB DR. LAL PATH LABS LTD. INE600L01024 Board Meeting New 2025-04-25 Yes 2025-04-01 2025-04-27 Financial results Dividend Other business Audited Standalone And Consolidated Yearly March 2025 Final The meeting of the Board of Directors is scheduled to be held on Friday, April 25, 2025 to inter-alia consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial Year ended March 31, 2025 and to consider recommending Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended March 31, 2025.